Zoom Registration: https://umass-amherst.zoom.us/meeting/register/b7Qip75BSvmSItRN9aqUtA
Abstract:
This talk will highlight the results of MindMics’ recent feasibility study on non-invasive blood pressure monitoring using in-ear infrasonic signals. Dr. Barnacka will discuss how this novel technology, validated through clinical research, can be integrated into both consumer earbuds and hearing aids, creating a new class of connected health devices. The presentation will explore the underlying infrasonic science, algorithmic advances, and the broader impact on cardiovascular health, preventive care, and data-driven wellness ecosystems.
Biography:
- Anna Barnacka, Founder and CEO, MindMics Inc.
- Dr. Anna Barnacka is the Founder and CEO of MindMics, a Boston-based healthtech company pioneering “In-Ear Infrasonic Hemodynography (IH)” — a patented technology that transforms earbuds and hearing aids into clinical-grade heart-health monitors. With dual PhDs in Physics and Astronomy and a NASA Einstein Fellowship at Harvard, Anna bridges physics, acoustics, and digital health innovation. Under her leadership, MindMics has achieved key clinical and commercial milestones, advancing a new era of personalized, non-invasive cardiovascular monitoring through everyday in-ear devices.